Technical Considerations for Demonstrating Reliability of Emergency-Use Injectors Submitted under a BLA, NDA or ANDA; Draft Guidance for Industry and FDA; Availability

1 organizations filed 1 public comment on Technical Considerations for Demonstrating Reliability of Emergency-Use Injectors Submitted under a BLA, NDA or ANDA; Draft Guidance for Industry and FDA; Availability, at the Food and Drug Administration. The comment window closed 2227d ago.

Commenters (1)

• Association for Accessible Medicinestrade assoc.

  1 filing · confidence 97%